Kevin Tan is CFO & Treasurer at Solid Biosciences Inc. (SLDB). They have made 8 open-market trades across 2 companies since 2021, most recently 2026-02-18.
CIK 0001884056
1 open-market purchase totalling $15K since 2021, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLDB | 104,826 | $582K |
| SELB | 77,000 | $68K |
| Total | $650K |
Shares reported on the most recent Form 4, priced at the 2026-02-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLDB | SELL | 2026-02-18 | 2026-02-18 | $5.82 | $31K | +6.7% | +20.5% | +4.7% |
| SLDB | SELL | 2026-02-04 | 2026-02-06 | $6.44 | $95K | -10.5% | +22.1% | +7.7% |
| SLDB | SELL | 2026-02-02 | 2026-02-02 | $6.44 | $173K | -5.1% | -4.2% | +12.6% |
| SLDB | SELL | 2026-01-13 | 2026-01-13 | $5.27 | $30K | +25.0% | +17.8% | +62.6% |
| SLDB | SELL | 2025-02-14 | 2025-02-18 | $3.96 | $13K | +2.6% | -13.8% | -46.8% |
| SLDB | SELL | 2025-01-10 | 2025-01-13 | $3.89 | $16K | -4.2% | +5.4% | -19.1% |
| SLDB | SELL | 2024-01-09 | 2024-01-11 | $8.20 | $32K | -1.5% | +2.3% | +37.3% |
| SELB | BUY | 2021-12-02 | 2021-12-06 | $3.03 | $15K | +1.3% | -1.9% | -49.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.